What You Should Know:
– Azalea Health, a provider of cloud-based healthcare IT solutions launches Clinical Assistant and Billing Assistant, two new AI-powered products designed to streamline workflows and improve efficiency for healthcare professionals.
– These…
Continue Reading
The use of AI in healthcare has evolved quite a bit over the past few years — with many healthcare organizations transitioning from a state of cautious experimentation to more serious attempts at scaled…
Continue Reading
The nursing shortage remains a key challenge for the healthcare industry, with federal authorities predicting a shortage of 63,720 full-time nurses in 2030. To address this problem, tech startups are developing tools to simplify…
Continue Reading
A webinar sponsored by Elation Health highlighted some of the challenges primary care practices face and how a more thoughtful, nuanced approach to health tech could transform healthcare practices. MedCity News Editor-in-Chief Arundhati Parmar…
Continue Reading
In this third episode of a three-week series of HIMSSCast, we again speak with UNC Health’s System Director for Analytical Solutions Greg Kuhnen. This time, he is joined by his colleague Ram Rimal, UNC’s…
Continue Reading
This year’s HIMSS conference in Las Vegas, which wrapped on Thursday, allowed healthcare technology leaders from around the world to convene and share ideas. As always, the event came with a slew of news…
Continue Reading
What You Should Know:
– ModMed, a provider of specialty-specific healthcare technology announced the upcoming launch of ModMed Scribe, an AI-powered ambient listening solution designed to revolutionize EHR documentation for dermatologists.
– The tool automates note-taking,…
Continue Reading
Background: Wearable technology is used by consumers worldwide for continuous activity monitoring in daily life but more recently also for classifying or predicting mental health parameters like stress or depression levels. Previous studies identified,…
Continue Reading
The DESTINY-Breast04 trial has recently demonstrated survival benefits of trastuzumab-deruxtecan (T-DXd) in metastatic breast cancer patients with low Human Epidermal Growth Factor Receptor 2 (HER2) expression. Accurate differentiation of HER2 scores has now become…
Continue Reading
What You Should Know:
– Abridge announced that its AI platform to support clinical conversations will be utilized by Memorial Sloan Kettering Cancer Center (MSK) clinicians in an extensive rollout that will take place throughout 2025…
Continue Reading
